These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1778796)

  • 1. New polyenic antibiotics active against gram-positive and gram-negative bacteria. V. Mode of action of enacyloxin IIa.
    Watanabe T; Suzuki T; Izaki K
    J Antibiot (Tokyo); 1991 Dec; 44(12):1457-9. PubMed ID: 1778796
    [No Abstract]   [Full Text] [Related]  

  • 2. New polyenic antibiotics active against gram-positive and gram-negative bacteria. VII. Isolation and structure of enacyloxin IVa, a possible biosynthetic intermediate of enacyloxin IIa.
    Watanabe T; Shima J; Izaki K; Sugiyama T
    J Antibiot (Tokyo); 1992 Apr; 45(4):575-6. PubMed ID: 1592689
    [No Abstract]   [Full Text] [Related]  

  • 3. New polyenic antibiotics active against gram-positive and gram-negative bacteria. IV. Structural elucidation of enacyloxin IIa.
    Watanabe T; Sugiyama T; Takahashi M; Shima J; Yamashita K; Izaki K; Furihata K; Seto H
    J Antibiot (Tokyo); 1992 Apr; 45(4):470-5. PubMed ID: 1592680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New polyenic antibiotics active against gram-positive and gram-negative bacteria. VI. Non-lactonic polyene antibiotic, enacyloxin IIa, inhibits binding of aminoacyl-tRNA to A site of ribosomes.
    Watanabe T; Okubo N; Suzuki T; Izaki K
    J Antibiot (Tokyo); 1992 Apr; 45(4):572-4. PubMed ID: 1375592
    [No Abstract]   [Full Text] [Related]  

  • 5. New polyenic antibiotics active against gram-positive and gram-negative bacteria. VIII. Construction of synthetic medium for production of mono-chloro-congeners of enacyloxins.
    Watanabe T; Sugiyama T; Chino K; Suzuki T; Wakabayashi S; Hayashi H; Itami R; Shima J; Izaki K
    J Antibiot (Tokyo); 1992 Apr; 45(4):476-84. PubMed ID: 1534321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New polyenic antibiotics active against gram-positive and gram-negative bacteria. IX. Reclassification of a strain W-315 producing enacyloxins.
    Watanabe T; Sugiyama T; Izaki K
    J Antibiot (Tokyo); 1994 Apr; 47(4):496-8. PubMed ID: 8195051
    [No Abstract]   [Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of simplified side chains of the macrolide antibiotic etnangien.
    Altendorfer M; Irschik H; Menche D
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5731-4. PubMed ID: 22832317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Polyene Natural Product Thailandamide A Inhibits Fatty Acid Biosynthesis in Gram-Positive and Gram-Negative Bacteria.
    Wu Y; Seyedsayamdost MR
    Biochemistry; 2018 Jul; 57(29):4247-4251. PubMed ID: 29975047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotics A21459 A and B, new inhibitors of bacterial protein synthesis. I. Taxonomy, isolation and characterization.
    Selva E; Gastaldo L; Saddler GS; Toppo G; Ferrari P; Carniti G; Goldstein BP
    J Antibiot (Tokyo); 1996 Feb; 49(2):145-9. PubMed ID: 8621354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Trojan-Horse Strategy Including a Bacterial Suicide Action for the Efficient Use of a Specific Gram-Positive Antibiotic on Gram-Negative Bacteria.
    Schalk IJ
    J Med Chem; 2018 May; 61(9):3842-3844. PubMed ID: 29683323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative sensitivity of clinical strains of gram-positive and gram-negative microorganisms to antibacterial antibiotics].
    Nekhorosheva AG; Khantimer EI
    Antibiot Med Biotekhnol; 1986 Apr; 31(4):291-4. PubMed ID: 3717927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxymethyl-oxazolidin-2-one antibacterials. Actelion Pharmaceuticals: WO2008062379.
    Phillips OA; Sharaf LH
    Expert Opin Ther Pat; 2009 Apr; 19(4):529-40. PubMed ID: 19441931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial effects of poly(2-(dimethylamino ethyl)methacrylate) against selected gram-positive and gram-negative bacteria.
    Rawlinson LA; Ryan SM; Mantovani G; Syrett JA; Haddleton DM; Brayden DJ
    Biomacromolecules; 2010 Feb; 11(2):443-53. PubMed ID: 20025269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for non-polyenic antifungal antibiotics produced by rare Actinomycetales.
    Hacène H; Sabaou N; Bounaga N; Lefebvre G
    Microbios; 1994; 79(319):81-5. PubMed ID: 7968663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of LY264826, an investigational glycopeptide antibiotic, against gram-positive bloodstream isolates and selected gram-negative bacilli.
    Perl TM; Wenzel RP; Jones RN
    J Antimicrob Chemother; 1992 May; 29(5):596-8. PubMed ID: 1624399
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanisms of antimicrobial resistance].
    Hori S; Hiramatsu K
    Nihon Rinsho; 1994 Feb; 52(2):327-31. PubMed ID: 8126881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activities of topical antibiotics against conjunctival isolates.
    Iqbal J; Rahman M; Kabir MS; Sharif AJ
    J Antimicrob Chemother; 1999 Apr; 43(4):611-2. PubMed ID: 10350400
    [No Abstract]   [Full Text] [Related]  

  • 18. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
    Drugs Exp Clin Res; 1987; 13(9):555-61. PubMed ID: 3480796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of bile on bacterial sensitivity to antibiotics].
    Veselov AIa
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):232-3. PubMed ID: 4015064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Patterns of susceptibility to 19 antibiotics of bacteria isolated from blood cultures in a reference hospital in Mexico City].
    Giraud MC; Calva JJ; Huazano F; Ponce de León S; Ruiz-Palacios G
    Rev Invest Clin; 1986; 38(1):7-14. PubMed ID: 3738270
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.